Cancer-Associated Thrombosis, With a Focus on Ischemic Heart Disease.
Cancer is widely recognized as one of the major risk factors for thrombosis, and cancer-associated thrombosis (CAT) is a concept that also encompasses arterial and venous thromboembolism.
APA
Hara T, Sata M (2026). Cancer-Associated Thrombosis, With a Focus on Ischemic Heart Disease.. Circulation journal : official journal of the Japanese Circulation Society, 90(4), 371-375. https://doi.org/10.1253/circj.CJ-25-0627
MLA
Hara T, et al.. "Cancer-Associated Thrombosis, With a Focus on Ischemic Heart Disease.." Circulation journal : official journal of the Japanese Circulation Society, vol. 90, no. 4, 2026, pp. 371-375.
PMID
40887291
Abstract
Cancer is widely recognized as one of the major risk factors for thrombosis, and cancer-associated thrombosis (CAT) is a concept that also encompasses arterial and venous thromboembolism. The risk factors for CAT of clinical concern are assumed to be a complex combination of patient-related factors, the cancer itself, factors related to anticancer therapy, tissue factors expressed on cancer cell membranes, and cytokines released by cancer cells to increase inflammation and coagulation at remote sites. In addition, some anticancer agents are known to damage vascular endothelial cells and cause thrombus formation; early diagnosis and treatment of CAT is recommended because CAT is a significant risk factor for poor prognosis in cancer patients.
MeSH Terms
Humans; Thrombosis; Neoplasms; Myocardial Ischemia; Risk Factors; Antineoplastic Agents
같은 제1저자의 인용 많은 논문 (5)
- Nationwide Real-World Outcomes of Robot-Assisted Radical Prostatectomy Using the Hinotori Surgical Robot System in Japan.
- Enhanced release of ciliary extracellular vesicles suppresses cell migration and promotes cell aggregation.
- Real-World Safety and Early Effectiveness of First-Line Enfortumab Vedotin Plus Pembrolizumab with Routine Dexamethasone Premedication in Advanced Urothelial Carcinoma.
- Pathologic complete response to enfortumab vedotin plus pembrolizumab in node-positive urothelial carcinoma: a case report.
- Recent Findings in N6-Methyladenosine Modification and Significance in Pancreatic Cancer.